Skip to content
Review Open access

Artificial intelligence in tissue engineering and regenerative medicine: from algorithmic capability to intelligent integration

Sep 2026 · Frontiers in Bioengineering and Biotechnology · Vol 14 · 0 citations · 61 references
Medicine

TL;DR

A review of AI’s use as a framework for knowledge extraction, experimental planning, decision support, experimental execution, data generation, interpretation, and scientific communication in tissue engineering and regenerative medicine concludes that many important gaps in AI-enabled TERM are not algorithmic but conceptual, methodological, and educational.

Abstract

Artificial intelligence (AI) is increasingly integrated throughout the tissue engineering and regenerative medicine (TERM) pipeline, from literature synthesis, experimental design, and automation to image analysis, biological modeling, and knowledge dissemination. However, TERM differs fundamentally from many domains where AI has succeeded. Biological heterogeneity, limited datasets, evolving protocols, sparse ground truth, and high translational stakes constrain the development and deployment of AI-driven approaches. Consequently, AI should be seen as a collection of purpose-specific tools whose suitability, risks, and validation requirements depend on the context. This review examines how AI can be intelligently integrated across the TERM workflow, emphasizing how intended purpose, biological reality, and translational constraints shape technology selection. We examine AI’s use as a framework for knowledge extraction, experimental planning, decision support, experimental execution, data generation, interpretation, and scientific communication. Key challenges include limited generalizability, uncertainty, validation, accountability, and the risk of confusing predictive performance with biological or mechanistic insight. We argue that many important gaps in AI-enabled TERM are not algorithmic but conceptual, methodological, and educational. Future progress will depend on purpose-aware AI literacy, uncertainty-aware modeling, validation strategies, human-in-the-loop workflows, and establishing community standards for transparency, reproducibility, and translation. Ultimately, AI should not be a shortcut around biological complexity, but a means of engaging with that complexity more explicitly and responsibly. Across the TERM pipeline, AI is best viewed as an amplifier of biological evidence and scientific reasoning rather than a substitute, with its greatest impact arising from intelligent integration into scientific practice rather than increasingly intelligent algorithms alone.

Read PDF

Similar papers

Review Open access Oct 2026

Artificial Intelligence in Diagnostic Pathology: A Narrative review on Current Applications, Emerging Challenges, and Future Perspectives

Advancements in digital pathology and whole-slide imaging have enabled Artificial Intelligence (AI) to emerge as a transformative tool in diagnostic pathology. AI has enabled the automated analysis of histopathological images, improving diagnostic accuracy and reproducibility, as well as workflow efficiency. The aim of...

Alka Yadav, Mithilesh Yadaw · 0 citations
Review Open access Aug 2026

ARTIFICIAL INTELLIGENCE IN MODERN MEDICINE: A COMPREHENSIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE PERSPECTIVES

This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation.

Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al. · 0 citations
#generative ai Review Open access Sep 2026

Artificial intelligence in healthcare: Technical advances, clinical integration, and future perspectives

This narrative review examines the evolution of artificial intelligence (AI) in healthcare, with a focus on the transition from early rule-based systems to modern deep learning architectures and their integration into clinical practice. We examine foundational technologies, including convolutional neural networks for i...

Abdulkadir Yıldırım, Ö. Özdemi̇r · 0 citations
Review Sep 2026

Artificial Intelligence in Biomaterials: Revolutionizing Design and Manufacturing.

Biomaterials are indispensable to modern healthcare, yet their development remains hindered by traditional trial-and-error approaches that are costly, time-intensive, and inefficient. Artificial intelligence (AI) offers a powerful alternative, but most existing reviews treat AI merely as a computational tool for proper...

Yi-Chen Liu, Zhi-Ting Wang, Hao-Jie Wei et al. · 1 citation
Review Open access Aug 2026

From pixels to patterns: the AI revolution in stem cell-derived models

Artificial intelligence (AI) is rapidly transforming stem cell and developmental biology, offering new strategies to analyze, interpret and optimize complex, dynamic systems such as organoids and stem cell-derived embryo models. In this Perspective, we chart the integration of AI into image-based analysis of stem cell...

Luca Deininger, Paolo Caldarelli, Magdalena Zernicka-Goetz et al. · 1 citation
#federated learning Review Open access Sep 2026

Applications and challenges of artificial intelligence in cancer management

Artificial intelligence (AI) is increasingly transforming cancer management by enabling the analysis of complex multimodal data generated across the cancer care continuum. This structured narrative review synthesizes current applications of AI, machine learning, and deep learning in cancer detection, imaging diagnosis,...

Eva Rahman Kabir, N. Mustafa, Zara Sheikh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.